Stay updated on SNDX-5613 Combo with Chemo in Relapsed Leukemia Clinical Trial
Sign up to get notified when there's something new on the SNDX-5613 Combo with Chemo in Relapsed Leukemia Clinical Trial page.

Latest updates to the SNDX-5613 Combo with Chemo in Relapsed Leukemia Clinical Trial page
- Check2 days agoChange DetectedThe web page has been updated to include new recruiting locations for clinical trials across Canada and the United States, with specific contact information and principal investigators listed. Additionally, the number of study locations has increased from 69 to 79, and a modernization of the ClinicalTrials.gov data ingest is planned for June 2025.SummaryDifference6%
- Check9 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.4%
- Check16 days agoChange DetectedDifference0.2%
- Check23 days agoChange DetectedDifference0.3%
- Check31 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.4%
- Check38 days agoChange DetectedDifference0.5%
Stay in the know with updates to SNDX-5613 Combo with Chemo in Relapsed Leukemia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SNDX-5613 Combo with Chemo in Relapsed Leukemia Clinical Trial page.